Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 9/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17876143 | 0.96 | ALOX5 (0.47) | ALOX5GGPS1PRKDCPTGES2PLA2G2A | |
| SCHEMBL17876157 | 0.96 | ALOX5 (0.47) | ALOX5GGPS1PRKDCPTGES2PLA2G2A | |
| SCHEMBL17876188 | 0.93 | ALOX5 (0.58) | ALOX5GGPS1PRKDCPTGES2MEN1 | |
| SCHEMBL17876195 | 0.90 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2MEN1 | |
| SCHEMBL17876189 | 0.89 | ALOX5 (0.52) | ALOX5GGPS1PRKDCPTGES2MEN1 | |
| SCHEMBL17876191 | 0.89 | ALOX5 (0.52) | ALOX5GGPS1PRKDCPTGES2PLA2G2A | |
| SCHEMBL17876193 | 0.88 | ALOX5 (0.45) | ALOX5GGPS1PRKDCPTGES2 | |
| SCHEMBL17876208 | 0.88 | PLA2G2A (0.38) | ALOX5GGPS1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL17876127 | 0.88 | ALOX5 (0.53) | ALOX5GGPS1PRKDCPTGES2MEN1 | |
| SCHEMBL17876190 | 0.87 | ALOX5 (0.52) | ALOX5GGPS1PRKDCPTGES2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | ALOX5 3059/4885GGPS1 1622/4885PRKDC 4858/4885 |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALOX5 3059/4885GGPS1 1622/4885PRKDC 4858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.